Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
Số trang: 13
Loại file: pdf
Dung lượng: 7.77 MB
Lượt xem: 24
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Emerging proof shows that abnormal lipometabolism affects invasion, metastasis, stemness and tumor microenvironment in carcinoma cells. However, molecular markers related to lipometabolism have not been further established in breast cancer. In addition, numerous studies have been conducted to screen for prognostic features of breast cancer only with RNA sequencing profiles.
Nội dung trích xuất từ tài liệu:
Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
Nội dung trích xuất từ tài liệu:
Novel lipometabolism biomarker for chemotherapy and immunotherapy response in breast cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Tumor microenvironment Breast cancer Emerging proof Abnormal lipometabolism Carcinoma cells Prognostic featuresGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 166 0 0 -
6 trang 165 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 138 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 107 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 34 0 0
-
12 trang 33 0 0